We are live on ! Find out more
PPBT icon

Purple Biotech

19 hedge funds and large institutions have $513K invested in Purple Biotech in 2025 Q4 according to their latest regulatory filings, with 6 funds opening new positions, 5 increasing their positions, 4 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

1,166% more capital inflows, than outflows

Capital inflows: $518K | Capital outflows: $40.9K

100% more first-time investments, than exits

New positions opened: 6 | Existing positions closed: 3

25% more repeat investments, than reductions

Existing positions increased: 5 | Existing positions reduced: 4

19% more funds holding

Funds holding: 16 → 19 (+3)

7.17% more ownership

Funds ownership: 1.47% → 8.64% (+7.2%)

73% less call options, than puts

Call options by funds: $9K | Put options by funds: $33K

Holders
19
Holders Change
+3
Holders Change %
+18.75%
% of All Funds
0.23%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
6
Increased
5
Reduced
4
Closed
3
Calls
$9​K
Puts
$33​K
Net Calls
-⁠$24​K
Net Calls Change
-⁠$24​K

PPBT Hedge Fund Activity: Q4 2025 in Review

19 of the 8,318 institutional investors tracked by Wall St. Rank reported a position in Purple Biotech (PPBT) for Q4 2025, worth a combined $513K — up 576% from $75.9K a quarter earlier.

Buyers outnumbered sellers: 6 funds opened new PPBT positions and 3 closed out — a net gain of 3 holders — while 5 added to existing stakes and 4 trimmed.

The largest buyer was Susquehanna International Group, opening a new position worth an estimated $341K. The largest seller was Virtu Financial, exiting entirely with an estimated $28K sold.

  • 19 institutional investors held Purple Biotech (PPBT) as of Q4 2025, up from 16 in Q3 2025.
  • Funds reported $513K of Purple Biotech stock for Q4 2025, up 576% quarter-over-quarter.
  • 6 funds opened new Purple Biotech positions in Q4 2025 and 3 closed out, a net change of +3 holders.
  • The largest Purple Biotech buyer in Q4 2025 was Susquehanna International Group, an estimated $341K added.
  • The largest Purple Biotech seller in Q4 2025 was Virtu Financial, an estimated $28K sold.

Based on aggregated 13F filings for Q4 2025.